$75M Orexigen Asset Sale Gets Approval In Del. Ch. 11
Bankrupt pharmaceutical company Orexigen Therapeutics Inc. received court approval Thursday in Delaware for a $75 million sale of its assets to stalking horse bidder Nalpropion Pharmaceuticals, bringing to fruition its hopes...To view the full article, register now.
Already a subscriber? Click here to view full article